Federation Des Caisses Desjardins Du Quebec Cellectis S.A. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Cellectis S.A. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 10,711 shares of CLLS stock, worth $19,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,711Holding current value
$19,601% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CLLS
# of Institutions
30Shares Held
15MCall Options Held
0Put Options Held
0-
Ubs Asset Management Americas Inc Chicago, IL4.72MShares$8.64 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.72MShares$8.63 Million0.2% of portfolio
-
B Group, Inc. Dallas, TX3.26MShares$5.96 Million3.46% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$2.63 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C3227KShares$415,1810.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $83.3M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...